A federal judge in Pennsylvania has given final approval to a $4 million settlement—of which $1.3 million is devoted to attorney fees—that resolves securities litigation against pharmaceutical company Zynerba.

The payout settles litigation involving claims that Zynerba violated the Securities and Exchange Act and was approved by U.S. District Judge Nitza Quiñones Alejandro of the Eastern District of Pennsylvania.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]